Sientra Inc (SIEN) Expected to Post Earnings of -$0.67 Per Share
Wall Street analysts expect Sientra Inc (NASDAQ:SIEN) to post ($0.67) earnings per share for the current fiscal quarter, according to Zacks. Two analysts have made estimates for Sientra’s earnings, with the lowest EPS estimate coming in at ($0.74) and the highest estimate coming in at ($0.59). Sientra reported earnings of ($0.92) per share during the same quarter last year, which would indicate a positive year over year growth rate of 27.2%. The business is expected to issue its next earnings report on Tuesday, March 12th.
According to Zacks, analysts expect that Sientra will report full year earnings of ($3.05) per share for the current financial year, with EPS estimates ranging from ($3.12) to ($2.95). For the next fiscal year, analysts expect that the firm will report earnings of ($2.52) per share, with EPS estimates ranging from ($2.63) to ($2.33). Zacks’ earnings per share averages are an average based on a survey of research firms that that provide coverage for Sientra.
Several equities analysts recently issued reports on the company. Maxim Group reaffirmed a “buy” rating and set a $20.00 price objective on shares of Sientra in a report on Monday. ValuEngine cut Sientra from a “strong-buy” rating to a “buy” rating in a report on Thursday, January 24th. Zacks Investment Research raised Sientra from a “sell” rating to a “hold” rating in a report on Wednesday, November 7th. Finally, BidaskClub cut Sientra from a “hold” rating to a “sell” rating in a report on Tuesday, November 13th. One research analyst has rated the stock with a sell rating, two have given a hold rating and nine have given a buy rating to the company. The stock presently has a consensus rating of “Buy” and an average price target of $22.63.
Several hedge funds and other institutional investors have recently added to or reduced their stakes in the company. Zurcher Kantonalbank Zurich Cantonalbank purchased a new stake in shares of Sientra in the fourth quarter valued at $29,000. Accredited Investors Inc. purchased a new stake in shares of Sientra in the third quarter valued at $200,000. Tarbox Family Office Inc. grew its position in shares of Sientra by 595.3% in the third quarter. Tarbox Family Office Inc. now owns 9,734 shares of the medical instruments supplier’s stock valued at $232,000 after purchasing an additional 8,334 shares during the period. Rhumbline Advisers grew its position in shares of Sientra by 50.6% in the fourth quarter. Rhumbline Advisers now owns 30,301 shares of the medical instruments supplier’s stock valued at $385,000 after purchasing an additional 10,180 shares during the period. Finally, MetLife Investment Advisors LLC grew its position in shares of Sientra by 55.2% in the third quarter. MetLife Investment Advisors LLC now owns 17,996 shares of the medical instruments supplier’s stock valued at $430,000 after purchasing an additional 6,397 shares during the period. 86.62% of the stock is owned by institutional investors.
Sientra, Inc, a medical aesthetics company, develops and sells medical aesthetics products to plastic surgeons in the United States. It operates through two segments, Breast Products and miraDry. The company offers silicone gel breast implants for use in breast augmentation and breast reconstruction procedures; breast tissue expanders; and scar management products under the Sientra, AlloX2, Dermaspan, Softspan, and BIOCORNEUM brand names.
Featured Article: Are all No-Load Funds Equal?
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Sientra Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sientra and related companies with MarketBeat.com's FREE daily email newsletter.